ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MIRO MiroMatrix Medical Inc

3.39
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
MiroMatrix Medical Inc NASDAQ:MIRO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.39 3.50 3.67 0 01:00:00

Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop

05/09/2023 9:04pm

GlobeNewswire Inc.


MiroMatrix Medical (NASDAQ:MIRO)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more MiroMatrix Medical Charts.

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023.

Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop for three sessions:

  • 9:00am ET: Bioengineering Transplantable Organs to Address the Transplant Need
  • 1:00pm ET: CMC Perspectives – Delivery, Stability, Potency
  • 3:30pm ET: Regulatory Perspectives

The Alliance for Regenerative Medicine Workshop will highlight scientific advances, CMC and regulatory insights, and funding perspectives.

About MiromatrixMiromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor ContactGreg Chodaczek347-620-7010 ir@miromatrix.com

Media Contact:Christina Campbell612-924-3793Christina@media-minefield.com

1 Year MiroMatrix Medical Chart

1 Year MiroMatrix Medical Chart

1 Month MiroMatrix Medical Chart

1 Month MiroMatrix Medical Chart

Your Recent History

Delayed Upgrade Clock